41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

ML Baroni; DS Martinez; FG Aguera; HR Ho; M Castella; S Zanetti; TV Hernandez; RD de la Guardia; J Castano; E Anguita; S Vives; J Nomdedeu; H Lapillone; Anne Bras; Vincent van der Velden; J Junca; P Marin; A Bataller; J Esteve; B Vick; I Jeremias; A Lopez; M Sorigue; C Bueno; P Menendez

doi:10.1136/jitc-2020-000845

41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, S Zanetti, TV Hernandez, RD de la Guardia, J Castano, E Anguita, S Vives, J Nomdedeu, H Lapillone, Anne Bras, Vincent van der Velden, J Junca, P Marin, A Bataller, J Esteve, B VickI Jeremias, A Lopez, M Sorigue, C Bueno, P Menendez

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

50 Citations (Scopus)

25 Downloads (Pure)

Original language	English
Article number	e000845
Journal	Journal for ImmunoTherapy of Cancer
Volume	8
Issue number	1
DOIs	https://doi.org/10.1136/jitc-2020-000845
Publication status	Published - 2020

Research programs

EMC MM-02-72-02
EMC NIHES-03-30-01
EMC NIHES-03-30-02

Access to Document

10.1136/jitc-2020-000845

Repub_127864_O-A.pdfFinal published version, 1.9 MB

http://hdl.handle.net/1765/127864

Cite this

Baroni, ML., Martinez, DS., Aguera, FG., Ho, HR., Castella, M., Zanetti, S., Hernandez, TV., de la Guardia, RD., Castano, J., Anguita, E., Vives, S., Nomdedeu, J., Lapillone, H., Bras, A., van der Velden, V., Junca, J., Marin, P., Bataller, A., Esteve, J., ... Menendez, P. (2020). 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo. Journal for ImmunoTherapy of Cancer, 8(1), Article e000845. https://doi.org/10.1136/jitc-2020-000845

@article{cfb9f0959d5a4788b0e40432c4087661,

title = "41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo",

author = "ML Baroni and DS Martinez and FG Aguera and HR Ho and M Castella and S Zanetti and TV Hernandez and \{de la Guardia\}, RD and J Castano and E Anguita and S Vives and J Nomdedeu and H Lapillone and Anne Bras and \{van der Velden\}, Vincent and J Junca and P Marin and A Bataller and J Esteve and B Vick and I Jeremias and A Lopez and M Sorigue and C Bueno and P Menendez",

year = "2020",

doi = "10.1136/jitc-2020-000845",

language = "English",

volume = "8",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BMJ Publishing Group",

number = "1",

}

Baroni, ML, Martinez, DS, Aguera, FG, Ho, HR, Castella, M, Zanetti, S, Hernandez, TV, de la Guardia, RD, Castano, J, Anguita, E, Vives, S, Nomdedeu, J, Lapillone, H, Bras, A, van der Velden, V, Junca, J, Marin, P, Bataller, A, Esteve, J, Vick, B, Jeremias, I, Lopez, A, Sorigue, M, Bueno, C & Menendez, P 2020, '41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo', Journal for ImmunoTherapy of Cancer, vol. 8, no. 1, e000845. https://doi.org/10.1136/jitc-2020-000845

TY - JOUR

T1 - 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

AU - Baroni, ML

AU - Martinez, DS

AU - Aguera, FG

AU - Ho, HR

AU - Castella, M

AU - Zanetti, S

AU - Hernandez, TV

AU - de la Guardia, RD

AU - Castano, J

AU - Anguita, E

AU - Vives, S

AU - Nomdedeu, J

AU - Lapillone, H

AU - Bras, Anne

AU - van der Velden, Vincent

AU - Junca, J

AU - Marin, P

AU - Bataller, A

AU - Esteve, J

AU - Vick, B

AU - Jeremias, I

AU - Lopez, A

AU - Sorigue, M

AU - Bueno, C

AU - Menendez, P

PY - 2020

Y1 - 2020

U2 - 10.1136/jitc-2020-000845

DO - 10.1136/jitc-2020-000845

M3 - Article

C2 - 32527933

SN - 2051-1426

VL - 8

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - 1

M1 - e000845

ER -